Stereotaxis Stock Performance

STXS
 Stock
  

USD 1.99  0.11  5.24%   

The entity has a beta of 1.9318, which indicates a somewhat significant risk relative to the market. Let's try to break down what Stereotaxis's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Stereotaxis will likely underperform. Even though it is essential to pay attention to Stereotaxis current price movements, it is always good to be careful when utilizing equity historical returns. Our philosophy towards measuring any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Stereotaxis exposes twenty-one different technical indicators, which can help you to evaluate its performance. Stereotaxis has an expected return of -0.84%. Please be advised to validate Stereotaxis semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if Stereotaxis performance from the past will be repeated at some point in the near future.
  
Refresh
Stereotaxis Performance
0 of 100
Over the last 90 days Stereotaxis has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in July 2022. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more

Structure and Payout Changes

Last Split Factor
1096:1000
Last Split Date
2013-11-04

Stereotaxis Price Channel

Quick Ratio3.33
Fifty Two Week Low1.7200
Target High Price13.00
Fifty Two Week High10.3000
Target Low Price7.00

Stereotaxis Relative Risk vs. Return Landscape

If you would invest  363.00  in Stereotaxis on March 28, 2022 and sell it today you would lose (164.00)  from holding Stereotaxis or give up 45.18% of portfolio value over 90 days. Stereotaxis is currently does not generate positive expected returns and assumes 4.82% risk (volatility on return distribution) over the 90 days horizon. In different words, 41% of stocks are less volatile than Stereotaxis, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 90 days Stereotaxis is expected to under-perform the market. In addition to that, the company is 3.35 times more volatile than its market benchmark. It trades about -0.17 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.11 per unit of volatility.

Stereotaxis Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Stereotaxis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Stereotaxis, and traders can use it to determine the average amount a Stereotaxis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1735

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsSTXS
Estimated Market Risk
 4.82
  actual daily
 
 41 %
of total potential
 
4141
Expected Return
 -0.84
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.17
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Stereotaxis is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stereotaxis by adding it to a well-diversified portfolio.

About Stereotaxis Performance

To evaluate Stereotaxis Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Stereotaxis generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Stereotaxis Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Stereotaxis stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Stereotaxis's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Investment(17.04) (18.38) 
Return on Average Assets(12.08) (13.03) 
Return on Average Equity(17.40) (18.77) 
Return on Invested Capital(0.23) (0.25) 
Return on Sales(0.1) (0.10) 
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri. Stereotaxis operates under Medical Instruments Supplies classification in the United States and is traded on AMEX Exchange. It employs 130 people.

Things to note about Stereotaxis

Checking the ongoing alerts about Stereotaxis for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Stereotaxis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Stereotaxis Alerts

Equity Alerts and Improvement Suggestions

Stereotaxis generated a negative expected return over the last 90 days
Stereotaxis may become a speculative penny stock
Stereotaxis has high historical volatility and very poor performance
Stereotaxis has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 35.02 M. Net Loss for the year was (12.06 M) with profit before overhead, payroll, taxes, and interest of 23.23 M.
Stereotaxis currently holds about 38.74 M in cash with (2.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Roughly 57.0% of the company shares are owned by institutional investors
Latest headline from www.benzinga.com: Global Electrophysiology Market Report - Featuring Abbott Laboratories, Boston Scientific - Benzinga
Additionally, take a look at World Market Map. Note that the Stereotaxis information on this page should be used as a complementary analysis to other Stereotaxis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Stereotaxis Stock analysis

When running Stereotaxis price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Stereotaxis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stereotaxis. If investors know Stereotaxis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stereotaxis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
148.6 M
Quarterly Revenue Growth YOY
-0.18
Return On Assets
-0.17
Return On Equity
-0.34
The market value of Stereotaxis is measured differently than its book value, which is the value of Stereotaxis that is recorded on the company's balance sheet. Investors also form their own opinion of Stereotaxis' value that differs from its market value or its book value, called intrinsic value, which is Stereotaxis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stereotaxis' market value can be influenced by many factors that don't directly affect Stereotaxis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stereotaxis' value and its price as these two are different measures arrived at by different means. Investors typically determine Stereotaxis value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stereotaxis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.